NCT06211699

Brief Summary

In this prospective randomized study, patients were divided into two groups: clips group and omentopexy group. The groups were compared in terms of postoperative decrease in hemoglobin and hematocrit values, preoperative and peroperative blood pressure values, duration of surgery, number of patients requiring erythrocyte suspension (ES) transfusion, length of hospital stay, hospital readmissions in the first 30-days postoperatively and early postoperative complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 25, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2023

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

January 7, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 18, 2024

Completed
Last Updated

January 18, 2024

Status Verified

January 1, 2024

Enrollment Period

5 months

First QC Date

January 7, 2024

Last Update Submit

January 17, 2024

Conditions

Keywords

Laparoscopic Sleeve GastrectomyBleedingStaple Line ReinforcementPostoperative First Month Readmission

Outcome Measures

Primary Outcomes (1)

  • Postoperative Bleeding

    The primary outcome of the study was to compare the two methods in terms of early postoperative bleeding. This comparison will be made with hemoglobin and hematocrit values measured at postoperative 6th hour, 24th hour and at discharge. The groups will be compared according to the decrease in hemoglobin and hematocrit values, whether ES displacement is required, and whether intervention is required.

    up to 3 Months

Secondary Outcomes (2)

  • Postoperative First Month Readmission

    30-days postoperatively

  • The duration of surgery (minutes)

    Intraoperative

Study Arms (2)

Omentopexy with Laparoscopic Sleeve Gastrectomy

ACTIVE COMPARATOR

Patients who underwent continuous through-and-through omentopexy of the omentum to the remnant stomach staple line after resection during Laparoscopic Sleeve Gastrectomy (omentopexy group).

Procedure: Omentopexy with Laparoscopic Sleeve Gastrectomy

Clips with Laparoscopic Sleeve Gastrectomy

ACTIVE COMPARATOR

Patients who underwent consecutive clippping along the staple line of the remnant stomach during Laparoscopic Sleeve Gastrectomy (clips group)

Procedure: Clips with Laparoscopic Sleeve Gastrectomy

Interventions

Patients with omentum sewed to the remnant gastric staple line during laparoscopic sleeve gastrectomy.

Omentopexy with Laparoscopic Sleeve Gastrectomy

Patients performed clips to the remnant gastric staple line during laparoscopic sleeve gastrectomy

Clips with Laparoscopic Sleeve Gastrectomy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The Patients who underwent LSG
  • Between the ages of 18 and 65,
  • A Body Mass Index (BMI) ≥ 40 or BMI ≥ 35 with at least one obesity-related comorbidity

You may not qualify if:

  • Patients who underwent other bariatric surgery procedures,
  • Patients who declined to be participate
  • uncontrolled hypertension
  • preoperative history of gastroesophageal reflux disease (GERD) symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Umraniye Training and Research Hospital

Istanbul, Umraniye, 34764, Turkey (Türkiye)

Location

MeSH Terms

Conditions

HemorrhagePostoperative ComplicationsPostoperative Nausea and Vomiting

Interventions

Surgical Instruments

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Intervention Hierarchy (Ancestors)

Surgical EquipmentEquipment and Supplies

Study Officials

  • Muhammed Taha Demirpolat, M.D.

    Umraniye Education and Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The primary surgeon is naturally not blinded to the patient groups and the other surgeon who records and evaluates the data is blinded to the patient groups. The patient was blind to the intervention.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Prospective Randomized Controlled Trial
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Prof., FEBS-MIS

Study Record Dates

First Submitted

January 7, 2024

First Posted

January 18, 2024

Study Start

July 1, 2023

Primary Completion

November 25, 2023

Study Completion

December 25, 2023

Last Updated

January 18, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations